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Dietary supplementation with 
hybrid palm oil alters liver function 
in the common Marmoset
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Hybrid palm oil, which contains higher levels of oleic acid and lower saturated fatty acids in comparison 
with African palm oil, has been proposed to be somehow equivalent to extra virgin olive oil. However, 
the biological effects of its consumption are poorly described. Here we have explored the effects of its 
overconsumption on lipid metabolism in a non-human primate model, the common marmoset. Dietary 
supplementation of marmoset with hyperlipidic diet containing hybrid palm oil for 3 months did not 
modify plasma lipids levels, but increased glucose levels as compared to the supplementation with 
African palm oil. Liver volume was unexpectedly found to be more increased in marmosets consuming 
hybrid palm oil than in those consuming African palm oil. Hepatic total lipid content and circulating 
transaminases were dramatically increased in animals consuming hybrid palm oil, as well as an 
increased degree of fibrosis. Analysis of liver miRNAs showed a selective modulation of certain miRNAs 
by hybrid palm oil, some of which were predicted to target genes involved in cell adhesion molecules 
and peroxisomal pathways. Our data suggest that consumption of hybrid palm oil should be monitored 
carefully, as its overconsumption compared to that of African palm oil could involve important 
alterations to hepatic metabolism.
In the last decades, the increasing consumption of processed and industrialized food with low nutritional quality 
has correlated with an increment of chronic diseases prevalence, such as obesity and cardiovascular diseases1,2. 
After it has been proved that partially hydrogenated fat–which is rich in trans isomers– was harmful to health, its 
use was forbidden in different countries. African Palm oil (AP) (extracted from Elaeis guineensis, african palm 
tree) has been the vegetable oil most widely used by the food industry as a trans-fat substitute even though it is 
rich in saturated fatty acids. However, recently, Chen et al. showed that for each kilogram of palm oil consumed 
annually per capita, the mortality due to ischemic cardiomyopathy increases the equivalent to 68 for 100,000 
deaths in developed countries1. Even if metabolic consequences of AP consumption are still controversial3, its 
consumption remains, a source of major concern within health policies regarding the reduction of cardiovascular 
and metabolic diseases risk.
Interspecific hybridization between African oil palm (Elaeis guineensis) and South American species, Elaeis 
oleifera has been exploited, with the objective of developing varieties as productive as African oil palm, together 
with resistance to diseases and pest, reduced height and improved nutritional value, specifically, increased mon-
ounsaturated oleic acid and reduced saturated fatty acids levels4,5. EMBRAPA (Empresa Brasileira de Pesquisa 
Agropecuária, Brazilian Corporation of Agricultural Research) has developed the first Brazilian interspecific 
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hybrid cultivar between Elaeis oleifera and Elaeis guineensis, which has all these characteristics, i.e. high produc-
tivity and improved nutritional value6. In this context, hybrid palm oil (HP) has been proposed as a promising 
new lipid source for industrialized products and a substitute for AP that could bring benefits to human health.
Previous studies on the chemical composition of HP suggest that the ripening status influences the amount of 
antioxidant phenolic content in the fruit7. Regarding its fatty acid profile, Mozzon et al., suggested that hybridi-
zation seemed to modify the biosynthesis of fatty acids rather than their assembly in the triacylglycerols8. In fact, 
they found that the sn-2 position of triacylglycerols in HP was mainly esterified with oleic acid (≈10% increment 
compared to that of AP)8. This apparent healthier profile of fatty acids composition of HP was tested and com-
pared to that of extra virgin olive oil (EVOO) in dietary supplementation9,10. When consumed for three months, 
both oils increased the degree of unsaturation of erythrocyte membrane lipids9. Moreover, dietary supplemen-
tation with HP showed similar effects on plasma lipids composition compared to that of EVOO (no differences 
between both groups)10. Researchers have suggested that the observed beneficial effects of HP consumption sup-
port the concept of HP as a “tropical equivalent to olive oil”.
On the other hand, recent studies suggest that there is no clear evidence to conclude that dietary saturated fat 
is associated with an increased risk of CVD11–14. Furthermore, the metabolic consequences of AP consumption 
are still controversial. Its effects can be favorable or unfavorable when compared with other types of fat sources, 
according to the evaluated parameters3. According to Wilson et al.15, these controversial metabolic effects of 
AP can be justified by the high presence of tocopherols and tocotrienols in their fat. These tocols can promote 
an antithrombotic state by reducing platelet aggregation and modulating prostanoid synthesis. But once the fat 
is refined, bleached and deodorized, depending on the degree of processing, the antithrombotic properties are 
inhibited15. Moreover, although no detrimental side effects of monounsaturated fatty acids (MUFA) rich diets 
were reported, there is still no consensus regarding monounsaturated fatty acids consumption recommenda-
tions16. Indeed, some large studies also suggest that substitution of saturated fatty acids by MUFAs can increase 
the risk of ischemic heart disease13. In this context, whether the consumption of HP–enriched in MUFAs–should 
be promoted due to its putative beneficial effects is still unclear.
miRNAs are posttranscriptional regulators of gene expression. Increasing evidence suggests that miRNAs 
can be modulated by diet17. Indeed, fatty acids have been shown to influence miRNAs expression in different 
metabolic tissues including intestine18, adipose tissue19 and liver20. Whether saturated or MUFAs influence liver 
miRNA expression is poorly characterized21. Moreover, whether HP can influence miRNA expression is com-
pletely unknown.
The main objective of this study was to evaluate the effects of overconsumption of HP, source of unsaturated 
fatty acids–obtained from the interspecific hybrid grown in EMPRAPA/Brazil–, vs. that of AP, rich in saturated 
fatty acids on lipid metabolism, and to identify liver miRNAs that could be modulated by these dietary fatty acids. 
For this purpose, we used the common marmosets, a New World primate species that has great phylogenetic sim-
ilarity with humans, being omnivorous animals, with diversified eating habits and easy adaptation to experimen-
tal diets. Nonhuman primates have also a lipid metabolism that is similar to ours and are recognized as a good 
animal model for dyslipidemia and metabolic disorders studies22. The experimental design is shown at Fig. 1.
Results
Fatty acid profile of experimental diets. First, we decided to study the detailed lipid composition of the 
experimental diets (Table 1) in order to assess their differences. The fatty acid profile of the experimental diets is 
shown in Table 2 and it is compatible with the diets formulation, since 2% of soybean oil was added to prevent 
possible deficiencies in essential fatty acids. Even though, the original fatty acid profile of the fats was maintained 
in the diets (Table 1). African palm oil diet (AP) presented 6% more saturated fatty acids, mainly because of pal-
mitic acid content, and the HP diet (HP) showed 4% higher amounts of MUFAs, mainly due to oleic acid content.
Body weight evolution. Next, we decided to determine whether there were differences on food intake due 
to the experimental diets. Animals consumed normally the prepared diets during the intervention period, both 
during normocaloric and hyperlipidic phases. No apparent differences in food intake were observed. Despite the 
consumption of hyperlipidic diets, no significant changes in body weight during the nutritional intervention were 
observed, either when analyzed by sex or computing both sexes together (Supplementary Figure S1).
Biochemical parameters. Since we did not observe any apparent changes in body weight, we decided to 
determine whether the experimental diets had any effect on metabolism. Blood biochemical parameters, includ-
ing cholesterol and its fractions, glucose and liver function markers were analyzed (Fig. 2). Dietary ingestion of 
the experimental oils did not elicit any significant changes in lipid levels (Fig. 2). This was further confirmed when 
lipoprotein profiles were analyzed by FPLC (Supplementary Figure S2). However, glucose levels were significantly 
Figure 1. Experimental design.
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changed by the consumption of both hyperlipidic diets, showing decreasing levels for the first two months of 
nutritional intervention and then surprisingly increasing glucose levels on the last month, with a greater incre-
ment in HP group (p = 0.002) when compared to AP group (Fig. 2). Also the ratio AST/ALT was calculated as a 
marker for hepatocellular lesion23. As shown in Fig. 3, both groups had an increase in this parameter, however HP 
group showed significant higher values.
Liver volume analysis. The lack of major changes in body weight of the experimental animals prompted 
us to evaluate other parameters that may counterbalance this apparent lack of effects. Therefore, we decided to 
measure the liver volume as a surrogate of the assessment of the interference of experimental diets on animal’s 
metabolism. Liver volume was analysed by CT. As expected due to the consumption of hyperlipidic diets, liver 
volume of non-human primates consuming both diets elicited an abnormal increase. Figure 4 depicts the results 
Ingredients g/100 g
Ground Corn 8.80
Wheat middlings 8.50
Rice bran 8.00
Sucrose 19.50
Dehulled soybean meal 5.00
Casein 7.00
Powder milk 7.00
Albumin 11.20
Chicken meal 2.90
Soybean oil 2.00
Palm oil* 14.30
Fibre 2.00
Vitamins and minerals mix 3.86
Butylhydroxytoluene 0.02
Kcal/100 g 422.08
Protein 16%
Carbohydrate 43%
Lipid 41%
Table 1. Experimental diets composition shown as g/100 g. *African palm oil or hybrid palm oil.
Fatty acids (%) African Palm Hybrid Palm
Saturated FA
 Palmitic (C16:0) 35.88 ± 0.02 30.68* ± 0.30
 Stearic (C18:0) 5.55 ± 0.01 5.23 ± 0.02
∑ SFA 45.25 ± 0.13 39.20 ± 0.31
Monounsaturated FA
 Oleic (C18:1 9c) 37.11 ± 0.01 41.64* ± 0.15
∑ MUFA 43.90 ± 0.01 47.72 ± 0.34
Poliunsaturated FA
 LA (C18:2 9c 12c) 9.83 ± 0.16 11.23 ± 0.40
 AA (C20:4 5c, 8c, 11c, 14c) 0.08 ± 0.00 0.08  ± 0.00
∑ n-6 FA 10.11 ± 0.26 11.65 ± 0.21
 AAL (C18:3 9c 12c 15c) 0.54 ± 0.03 1.04 ± 0.01
 EPA (C20:5 5c, 8c, 11c, 14c, 17c) 0.11 ± 0.00 0.12 ± 0.00
 DHA (C22:6 4c, 7c, 10c, 13c, 16c, 19c) 0.03 ± 0.01 0.01 ± 0.00
∑ n-3 FA 0.69 ± 0.05 1.25 ± 0.08
∑ PUFA 10.82 ± 0.31 12.93 ± 0.13
Saturated/monounsaturated FA ratio 1.03 0.82
Saturated/poliunsaturated FA ratio 4.18 3.03
Table 2. Characterization of diets according to their fatty acid profiles. AP: African Palm Oil; HP: Hybrid 
Palm Oil. Σ SFA: sum of saturated fatty acids; Σ MUFA: sum of monounsaturated fatty acids; Σ PUFA: sum 
of polyunsaturated fatty acids; LA: linoleic acid; ALA: alfa linolenic acid; Σ n-6: sum of n-6 polyunsaturated 
fatty acids; Σ n-3: sum of n-3 fatty acids. AA: Arachidonic Acid; EPA: Eicosapentaenoic Acid; DHA: 
docosahexaenoic acid. Values are expressed as mean ± standard error (3 samples of each diet). *Means 
statistical difference at p < 0.05 HP vs. AP.
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of hepatic volume of the experimental animals. Both groups presented hepatic volume increment, even when 
values are corrected by body weight (Fig. 4B). The two experimental groups showed an increase in hepatic volume 
between the beginning and the end of the experimental diets. The AP group presented a 15% increase in hepatic 
volume, whereas, surprisingly, the HP group had a 30% increase, that is, twice that of the AP fed (Fig. 4A,B). 
When corrected for body mass, the values are slightly higher, maintaining the ratio of 16% increase for AP and 
31% for HP. However, while at the beginning of the experiment both groups had similar hepatic volume, by the 
end of it, the HP diet group presented a hepatic volume 19% higher than the AP group and, when corrected for 
Figure 2. Biochemical parameters analyzed during the nutritional intervention (n = 10 animals per group). AP: 
African Palm Group; HP: Hybrid Palm Group. Glucose, Total cholesterol, HDL cholesterol, LDL cholesterol, 
VLDL cholesterol, and triglycerides were determined with standard colorimetric methods. Values expressed as 
mean ± SEM. **Indicates a statistical difference at p < 0.02.
Figure 3. AST/ALT Ratio at the beginning and at the end of the study. (n = 9 animals per group). AP: African 
Palm Group; HP: Hybrid Palm Group.
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Figure 4. Hepatic volume of experimental animals at the beginning and at the end of the study. (n = 10 
animals per group). AP: African Palm Group; HP: Hybrid Palm Group. (A) Liver volume expressed in cm3. (B) 
Liver volume corrected by body weight. Values are expressed as mean ± standard error. *Indicates statistical 
significance at p < 0.05 and ** at p < 0.02. (C) Scanner images of marmosets fed with either AP or HP diet 
(representative images), both at the beginning and at the end of the nutritional intervention. Images were 
obtained by PET/CT Scan. (D) Gene expression analysis of fatty acid synthase (FASN) and hepatic nuclear 
factor 4 alpha (HNF4A) in liver samples of animals fed with AP or HP. n ≥ 7 per group. (E) Liver histological 
cross-sections from marmoset fed either AP or HP (Hematoxylin-eosin). Green arrowhead: microvesicular 
steatosis; red arrowhead: steatosis; yellow stars: inflammatory infiltrate. (F) Photomicrograph of cells with 
collagen staining (Sirius red). Histological analysis are representative of n = 3 animals per group.
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body weight, this difference increased to 25%. Lipid determination of liver tissues at the end of the experiment 
showed that AP had 3.08 ± 0.12% fat, while HP had ≈3-fold higher (9.84 ± 0.67%; P = 0.0001). Tissue analysis 
of the fatty acid synthase (FASN) gene showed an increased expression of the mRNA in animals consuming HP 
(Fig. 4D). While the hepatic nuclear factor 4 alpha (HNF4A), a gene involved in hepatic reparation process, also 
increased its mRNA expression by HP supplementation. Histological analysis showed an increase number of ste-
atotic cells and inflammatory infiltrate in animals consuming HP (Fig. 4E). Moreover, collagen staining (Fig. 4F) 
showed an increased degree of fibrosis in animals fed HP compared to that of AP.
Fatty acid composition of total lipids in liver tissues. To elicit the cause for the greater effect of HP diet 
on liver volume and fat content increase, we determined the fatty acid profile of liver tissue. As shown in Table 3, 
the differences between both groups for some fatty acids are very subtle and only two analysis showed statistical 
differences. The net changes, though, reflect a liver lipid composition poorer on unsaturated fatty acids when 
compared with the diet lipid composition. This is shown both at the ∑ PUFA (increased in the HP diet vs. the AP 
diet but decreased in the HP fed liver vs. the AP fed liver) and the saturated/polyunsaturated FA ratio (decreased 
in the HP diet vs. the AP diet but slightly increased in the HP fed liver vs. the AP fed liver).
The 16:1/16:0 ratio showed significant higher levels in HP diet indicating either increased hepatic 
Stearoyl-CoA desaturase (SCD1) or higher availability of palmitic acid (C16:0) as a substrate for the enzymatic 
reaction (p < 0.0001), suggesting that the increased SCD1 activity in the liver of HP group might be involved in 
the process of hepatic lipid accumulation with potential to promote NAFLD (Table 3).
Hybrid palm diet modifies hepatic miRNAs. Hepatic lipid accumulation, such as it is observed in 
NAFLD, can be promoted by various causes, among them the upregulation of lipid metabolism related genes 
expression, leading to an increased hepatic de novo lipogenesis24,25. Epigenetic factors, such as DNA methylation, 
histone modifications or microRNAs (miRNAs), have been involved in liver disease26,27. Over the last decade, 
miRNAs have emerged as critical regulators of lipid metabolism (for a review, see Aryal et al.28 and herein ref-
erences). In order to gain insight into possible molecular mechanisms modulated by HP that could be leading 
to the observed hepatic lipid accumulation, we next evaluated hepatic miRNAs. A selection of miRNAs from 
marmoset, which are conserved in humans (see Materials and Methods for details), was first screened in both 
male (Fig. 5A) and female liver samples (Fig. 5B) obtained from biopsies. A list of 45 miRNAs (sum of male and 
female miRNAs whose expression was found to be modulated) was next validated with a different set of primers 
by qRT-PCR. 10 miRNAs were consistently validated (Fig. 6) to be differentially expressed by HP diet, namely 
miR-592, miR-488-3p, miR-339-3p, miR-17-5p-1, miR-877-5p, miR-15b-5p, miR-484-1, miR-4745-5p, let-7b-5p 
and miR-25-3p. The rest of the selected miRNAs for validation were not differentially modulated when assessed in 
both sexes (Supplementary Figure S3). Gene ontology analysis of predicted targets of these miRNAs showed that 
Fatty acids (%) African Palm Hibrid Palm
Saturated FA
 Palmitic (C16:0) 19.15 ± 0.92 17.78 ± 0.33
 Stearic (C18:0) 12.04 ± 1.27 13.24 ± 1.33
∑ SFA 32.66 ± 1.10 33.07 ± 1.64
Monounsaturated FA
 Palmitoleic (C16:1 9c) 1.01 ± 0.05 1.54* ± 0.06
 Oleic (C18:1 9c) 20.26 ± 1.41 22.36 ± 0.50
∑ MUFA 22.23 ± 1.45 24.61 ± 0.44
Poliunsaturated FA
 LA (C18:2 9c 12c) 22.11 ± 0.96 19.48 ± 1.29
 AA (C20:4 5c, 8c, 11c, 14c) 9.75 ± 1.19 8.51 ± 1.57
∑ n-6 FA 37.85 ± 2.19 35.89 ± 2.30
 AAL (C18:3 9c 12c 15c) 0.89 ± 0.09 0.94 ± 0.05
 EPA (C20:5 5c, 8c, 11c, 14c, 17c) 0.10 ± 0.02 0.16 ± 0.03
 DHA (C22:6 4c, 7c, 10c, 13c, 16c, 19c) 4.02 ± 0.35 3.51 ± 0.34
 ∑ n-3 FA 7.26 ± 0.48 6.30 ± 0.63
 ∑ PUFA 45.10 ± 2.12 42.20 ± 2.11
Saturated/monounsaturated FA ratio 1.49 ± 0.10 1.34 ± 0.05
Saturated/poliunsaturated FA ratio 0.73 ± 0.06 0.79 ± 0.08
16:1/16:0 ratio 0.05 ± 0.00 0.09* ± 0.01
18:1/18:0 ratio 1.76 ± 0.07 1.57 ± 0.08
Table 3. Fatty acid profile of liver tissue from the two experimental groups. AP: African Palm Oil; HP: Hybrid 
Palm Oil. Σ SFA: sum of saturated fatty acids; Σ MUFA: sum of monounsaturated fatty acids; Σ PUFA: sum 
of polyunsaturated fatty acids; LA: linoleic acid; ALA: alfa linolenic acid; Σ n-6: sum of n-6 polyunsaturated 
fatty acids; Σ n-3: sum of n-3 fatty acids. AA: Arachidonic Acid; EPA: Eicosapentaenoic Acid; DHA: 
docosahexaenoic acid. Values are expressed as mean ± standard error (n = 8–10). ∗Means statistical difference 
at p < 0.05).
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neuron projection development (GO:0031175), or pathways related to nicotinic acetylcholine receptor signalling 
(Panther:P00044), cell adhesion molecules (KEGG:04514) or peroxisome (KEGG:04146) are among the possible 
targets of these miRNAs (Supplementary Table S1).
Discussion
Dietary FAs play significant roles in the cause and prevention of cardiovascular disease. Palm oil may be an 
unhealthy fat, mainly extracted from E. guineensis (AP) because of its high saturated FA content, specifically pal-
mitic acid (C16:0 ≈ 44%), and its use in foods and food products has been somewhat discouraged. On the other 
hand, although controversies persist concerning the association between the intake of dietary saturated fatty acids 
and CVD risk29–31, several studies have shown the beneficial role of diets with a relatively high MUFA content on 
CVD risk factors, obesity and diabetes. These beneficial MUFA are mainly provided by the Mediterranean diet 
and, specifically, by olive oil, oleic acid-rich oils32. In this context, higher degree of FA unsaturation is therefore 
a desirable characteristic to alter in palm oil. Hybrids between E. guineensis × E. oleifera excited much interest, 
because of the shorter size, more resistance to several diseases, higher desaturation of palm oil and, in particular, 
putative healthier oil, constituting an alternative approach to increase oleic acid content in palm oil4,5. Seeds of 
high yielding interspecific hybrids palm oils (HP) are produced in Brazil by EMBRAPA/Dendê do Pará S.A.12 
(MANICORÉ hybrids), using wild E. oleifera palms indigenous to the Coari and Manicoré municipalities in the 
Amazon river basin.
In the present study, our results of fatty composition revealed significant differences between the HP and AP 
produced in Brazil, where HP presents a higher level of oleic acid (49.6 ± 0.01 vs 42.1 ± 0.01 in original oils, data 
not shown) together with a lower palmitic acid content (32.8 ± 0.1 vs 40.9 ± 0.2 in original oils, data not shown). 
Furthermore, as expected, a high-fat diet manufactured from the HP showed higher contents of monounsaturated 
Figure 5. HP supplementation modulates miRNA expression. Volcano plots of hybrid palm oil-modulated 
miRNAs in marmoset liver. (A) Males; (B) Females. miRNA expression was analysed by RT-qPCR (n = 9 
animals per group). Labelled miRNAs were selected for further validation.
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and lower of saturated fatty acids compared to AP. However, the amount of the polyunsaturated or essential fatty 
acid, linoleic acid, does not differ significantly (Table 2). Comparing our results with those of Mozzon et al.8, the 
fatty acid composition of the HP grown in Colombia showed higher percentage of oleic acid (54.6% ± 1.0) and 
similar saturated fatty acid content (33.5% ± 0.5), while the percentage of others fatty acids does not undergo sig-
nificant changes. Moreover, a recent positive effect of HP –grown in Colombia– on human plasma lipids has been 
observed, where after three months of 25 ml per day HP consumption, the total cholesterol levels decreased by 
6.3%, whereas LDL-C concentration decreased by more than 13%10. This is the only study found in the literature 
that shows similar effects on plasma lipids composition compared to EVOO10. On the other hand, our results pro-
vide evidence that a high-fat diet richer in HP –grown in Brazil– does not result on a healthier liver lipid content 
profile in marmoset.
The increased liver volume of animals consuming HP diet prompted us to search for other markers of liver 
damage. The AST/ALT ratio is an index used in clinical practice as a non-invasive method of determining the 
progression of various liver diseases, especially NAFLD23. We found that HP diet dramatically increased this ratio, 
suggesting an increase in liver injury in this group, which is in accordance with disease progression observed in 
humans33. Excessive accumulation of lipids in the liver is also a characteristic of NAFLD, which leads to liver 
damage when inappropriately metabolized. Besides that, the hyperglycaemia founded in HP group (Fig. 2) at the 
end of the study, also indicates impairment in the liver function, once it is known that fat accumulation in the 
liver suppresses insulin signaling in hepatocytes, leading to hyperglycemia34. Our results also show a three-fold 
increase in lipid accumulation in the liver, without any apparent changes in plasma lipid levels or lipoprotein pro-
file. Thus, some of the discrepancies between the present study and the literature can be explained by differences 
in important variables such as the reference or control group, which in the present study is the African palm 
group and/or the context of the diet which is a high-fat diet. Indeed, the major difference between both groups 
was just the different amount of oleic acid, which at that concentration (49.6% ± 0.01 vs 42.1% ± 0.01 in original 
oils, data not shown) might not induce appreciable changes in circulating lipids levels. In the context of a high 
fat diet, it has been previously described that some positive effects related to dietary fatty acids can be lost under 
high-fat intake35, such as in our study. Indeed, animal studies when fed high fat diet have shown that palmitic 
acid or palm oil enriched diet can induce obesity, hepatic steatosis or changes in the microbiota36,37. In humans, 
only one study shows that overfeeding SFAs from palm oil increases hepatic fat compared to that of n-6 PUFAs 
(sunflower oil)38. Thus, whether this HP grown in Colombia, when consumed in large quantities in the diet also 
produce liver damage in humans, as observed here for marmosets, has not been evaluated.
There is evidence that the metabolic effects of dietary TAG depend not only on their FA composition but also 
on the stereochemical configuration of specific FA in the TAG molecule. In Colombia, Mozzon et al., suggested 
that hybridization seemed to modify the biosynthesis of fatty acids rather than their assembly in the triacylglyc-
erols8. In fact, they found that the sn-2 position of triacylglycerols in HP was mainly esterified with oleic acid 
Figure 6. Liver miRNAs modulated by HP diet. Hepatic miRNAs validated in both sexes. AP: African Palm 
Group; HP: Hybrid Palm Group. miRNA expression was analysed by RT-qPCR (n = 9 animals per group). 
Values are expressed as mean ± standard error. *Indicates statistical significance at p < 0.05.
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(≈10% increment compared to that of AP)8. This apparent healthier profile of fatty acids composition of HP 
was tested and compared to that of EVOO in dietary supplementation9,10. Although more direct experiments are 
required in the HPs produced in Brazil, it is possible that the HP grown in Colombia, due to its higher proportion 
of unsaturated FA chains in position 2 of the TAG molecule8, could be quickly oxidized, resulting in a significant 
impact on the circulating lipid levels when in dietary supplementation.
The finding in this study of increased total lipid in liver tissue from animals consuming HP diet, motivated 
us to study the ratio of C18:1/C18:0 and C16:1/C16:0 and therefore, SCD1 activity was indirectly estimated. The 
enzyme SCD1, which is the isoform predominantly expressed in the liver and adipose tissues, plays an important 
role in the synthesis of monounsaturated long-chain FAs from saturated fatty acyl-CoAs. According to Li et al.39, 
saturated fatty acids (such as palmitic acid, 16:0) exert lipotoxic activity in liver cells, inducing caspase activity 
and, therefore, apoptosis. To overcome this, liver cells upregulate the activity of SCD, because MUFAs (such as 
palmitoleic acid, 16:1) can be stored in cells without the toxic effects observed with saturated fatty acids. The 
authors suggest that the accumulation of fat in liver is a mechanism of adaptation to avoid liver cells death39. 
Hepatic SCD1 activity, has been shown to correlate with non-alcoholic fatty liver disease (NAFLD)40. In the 
present study, we observed increased 16:1/16:0 ratio in HP diet indicating a higher activity of the SCD1 enzyme, 
suggesting that, high-fat diet richer in HP –grown in Brazil– contributes to hepatic fat accumulation with poten-
tial to promote NAFLD. In fact, Puri and colleagues41 have previously performed lipidomic analysis on human 
healthy livers, and those of steatosis and non-alcoholic steatohepatitis patients. From their data we can obtain the 
SCD ratio for healthy (0.053), steatosis (0.076) or steatohepatitis (0.062) liver patients, which are within the same 
range of our findings. Yamada and colleagues42 analysed also similar groups and found a clear difference between 
healthy (0.10) and non-alcoholic steatohepatitis (0.13) patients. They also correlated these data with different 
histopathological analysis and showed a significant correlation between these ratios and the progression degree 
of NAFLD42. On the other hand, the increased glucose levels observed in the HP group, might be indicative of 
hyperinsulinemia, and insulin can also upregulate the activity and expression of SCD43. Overall, our data suggest 
that HP diet, by mechanisms still unknown, alters liver function when compared to that of AP supplementation. 
Whether or not this HP given in a normolipidemic diet also alters liver function, is a subject for future investiga-
tions in this experimental model.
In order to identify liver miRNAs that could be modulated by these high-fat diets richer in HP and AP, we 
evaluated hepatic miRNAs in this experimental model. To the best of our knowledge, no specific studies have 
been conducted either on the qualitative liver expression of miRNAs, or on their modulation by these hyperlipidic 
diets. miRNAs are powerful post-translational regulators that mediate gene regulation by providing the means of 
fine tuning entire gene networks. In this manner, the modulation of a small number of miRNAs allows the regula-
tion of many genes involved in different pathways. The characterization of the miRNAs modulated by the Hybrid 
palm diet vs. the African palm diet, has allowed us to identify 10 miRNAs whose expression is consistently altered 
under the HP diet on marmosets of both sexes. Analysing the putative gene targets to these miRNAs and studying 
the pathways in which these genes are involved by gene ontology, five pathways have risen that could be involved 
and/or mediating the effects observed on the experimental animals under the HP diet. It is worth to highlight 
three of these pathways due to their relationship to lipid metabolism: (a) Nicotinic acetylcholine receptor sign-
aling pathway, nicotinic acetylcholine receptors (nAChRs) are known to interact with anti-inflammatory path-
ways and have been implicated in control of appetite and body weight, as well as lipid and energy metabolism44; 
(b) Cell adhesion molecules (CAMs), adhesion of leukocytes to endothelial cells via cell adhesion molecules is 
thought to be pivotal in the initiation of atherosclerosis45, and it has been described that certain miRNAs play 
important roles in lipid uptake and adhesion molecule expression in oxLDL-effected macrophages/DCs46; and 
(c) Peroxisome, it is well known the role that peroxisomes play in cellular lipid metabolism, being involved in key 
pathways such as fatty acid beta-oxidation, etherphospholipid biosynthesis and fatty acid alpha-oxidation47. These 
pathways could be mediating an inflammatory response to the observed hepatic damage (namely, increment of 
AST/ALT ratio and liver size) in an attempt to recover normal liver function. Interestingly, putative gene targets 
to some of these miRNAs were also related to glucose metabolism or glucose transport, such as Sirtuin 1 (Sirt1) 
or Sortilin 1 (Sort1), respectively, and several other insulin signalling/receptor related genes including: Vamp2, 
Hnf4a, Cacna1c, Stx1a, Cacna1d, Snap25, Grb2, Fgf23, Fgf1, or Igf1r. Future experiments will determine whether 
the expression levels of the putative target genes are modulated by the HP diet.
Some limitations of the present study should be noted though. For instance, the limited number of subjects 
has reduced the possibility (if any) to find any differences attributed to sex, given the case that these differences 
exist. Indeed, sex differences may also influence lipid metabolism48. The inability to obtain liver biopsies (due to 
ethical concerns) at time 0 of the intervention, and the inability to obtain enough biopsied tissue for additional 
histological analysis, still the gold standard method for diagnosing liver disease despite its limitations49, has pre-
vented a more thorough and detailed characterization of the effects induced by the tested diets. The strength 
of our study relies on the use of marmoset as a non-human primate model and a strict control of the fed diet. 
Nonhuman primates have a lipid metabolism close to ours and provide a very good model for metabolic dis-
orders22. The control of the fed diet reduces the variability inherent to free will subjects, giving strength to the 
statistical analysis. Moreover, diet is known to change not only classically used biochemical parameters, but also 
novel biomarkers such as miRNAs50.
In conclusion, our study provides evidence that HP supplementation in the diet of the common marmoset can 
induce liver abnormalities not easily detected by classical biochemical parameters (i.e. plasma lipid levels). Our 
data suggest that overconsumption of HP should be monitored carefully, as its consumption, compared to that of 
AP, might rise important concerns related to hepatic metabolism. Further studies will be needed to discern the 
differences of HP supplementation with the variety used in other previous studies.
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Material and Methods
Animals. Twenty common marmosets (Callithrix jacchus, ten males and ten females) were used in this study. 
The animals were housed in couples in species-specific cages of stainless steel with internal sliding wall (squeeze-
back system), according to the established guidelines in the Guide for the Care and Use for Laboratory Animals51.
The animals were fed commercial New World monkey pellets (Megazoo® P25, Betim, MG, Brazil) and water 
ad libitum, as well as low-fat fruits and vegetables offered daily as environmental enrichment, to break the food 
monotony, following the recommendations of the National Council for Animal Experimentation Control52. Care 
and ambience followed the environmental enrichment protocol for callitrichidae as specified by the Husbandry 
Guidelines for Callitrichidae53.
The marmoset experiments were approved by the Ethics committee for the use of experimental animals of 
the Health Care Center of the Federal University of Rio de Janeiro, under reference number INJC014. All experi-
ments were performed in accordance with relevant guidelines and regulations.
Experimental diets. To perform the study, primates were divided into 2 groups (n = 10:5 males and 5 
females) subjected to two different diets: African Palm (AP) and Hybrid Palm (HP) groups. The dietary interven-
tion consisted of a 3-month metabolic insult with hyperlipidic (41% of the energetic value) and normoglicid diet, 
with a high glycemic index, that differed only in the lipid source of the diet: HP vs. AP. Experimental diets were 
made by Prag Soluções (São Paulo, BR), following the recommendations of the European Association of Zoos and 
Aquaria53 as showed in Table 1. Palm oils (E. guineensis and E. oleifera interspecific hybrid) were kindly provided 
by AGROPALMA (Belém, Pará, Brazil).
Body weight and biometry. Body mass was measured at each blood collection, once the animals were 
sedated. Biometrics were also performed at this moment to determine the measure of body length (from occipital 
protuberance up to the first coccygeal vertebra), tail (from first caudal vertebra to tail end), abdominal perimeter 
(measured where the umbilical scar is located) and thoracic perimeter (measured around the axillary region) with 
anthropometric tape (Fig. 1).
Collection and analysis of biological samples. Biochemical and hematological analyzes. At the begin-
ning of the study we characterized the animals running hematological and immunological analysis, as well as 
determining hepatic and renal status. Also, blood samples were taken before dietary intervention (basal) and after 
1, 2 and 3 months within the nutritional interventions (Fig. 1).
Blood collection. After 12 hours of fasting, animals were sedated with intramuscular ketamine (10 mg/kg) and 
blood was collected by puncture in the femoral vein (0.8 to 1.0 mL) and separated in aliquots with different anti-
coagulants: in tubes containing heparin (20 IU/ml blood) or EDTA (ethylenediaminetetraacetic acid, 1.8 mg/ml 
blood), as required to run the different intended analyzes. Samples with heparin were sent under refrigeration to 
Laborlife Clinical Analyzes (Rio de Janeiro) to determine biochemical parameters such as: total cholesterol and 
its fractions, triglycerides, and glycaemia by means of colorimetric chemical kinetic assays with an automated 
clinical analyzer (Metrolab 2300). The samples collected in EDTA were immediately centrifuged at 3,000 rpm 
for 15 minutes at 4 °C. Plasma and resulting erythrocytes were frozen at −80 °C for further plasma lipoprotein 
analysis by fast protein liquid chromatography (FPLC) and assessment of erythrocyte fatty acid profile by gas 
chromatography, respectively (Fig. 1).
Collection of hepatic tissue. For hepatic biopsy, at the end of the experiment, the animals were fasted for 12 hours 
and anesthetized with ketamine (7.5 mg/kg) and xylazine (1.5 mg/kg), both intramuscularly. The hepatic tissue 
was collected by laparotomy wedge biopsy. Samples were immediately frozen in liquid nitrogen and stored at 
−80 °C for further analysis (Fig. 1).
Histological analysis of hepatic tissue. Tissues (defrosted) from animals fed AP or HP were fixed in formalin, 
paraffin embedded, and sections were stained with hematoxylin and eosin (H&E) and Pico Sirius Red. Images 
were captured with a camera DP72 coupled in a microscope BX51, both Olympus. Three hepatic biopsies of each 
group were processed.
Fatty acid profile of diets and biological samples. The fatty acid profiles of the diets and hepatic tissue 
were determined by liquid-gas chromatography according to the AOCS Ce2b-11 method54, the internal standard 
C13:0 being added for quantification of the methyl esters.
The lipids of the experimental diets were extracted and purified using the Bligh and Dyer method55. The 
alkaline direct methylation method (Ce 2b-11), described by the American Oil Chemists’ Society56, was used for 
transesterification of the oils extracted from the diets, as well as for the extraction, purification, and transesterifi-
cation of the liver samples. Tridecanoic acid (13:0) (Sigma Chemical Co.) was added to each methylation tube as 
internal standard. Fatty acid methyl esters were separated and quantified using the Agilent Technologies 7890A 
CG System with a flame ionization detector and a 100 m × 0.25 mm capillary column with 0.2 µm inner diameter 
(Supelco Inc., PA, USA). Hydrogen was used as carrier gas. The fatty acid methyl esters were identified based on 
purified standards (Nu-Chek Prep. Inc., mix 463), and their quantification was performed as a function of the 
corresponding peak areas compared to that of the internal standard.
Liver volume measured by computer tomography (CT). CT scans were performed on all animals 
prior to and at the end of the dietary intervention in an Optima PET/CT560 equipment, located at the Nuclear 
Medicine Service of the Hospital Universitário Clementino Fraga Filho- Rio de Janeiro, UFRJ. The settings for CT 
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scans were 120 kVa, 80 mA and slices of 0.65 mm. The volume of the livers was calculated using OsiriX Lite v.7.0.4 
software, where each tomographic slice was manually segmented, and its volume was calculated later. A 3D image 
of the animal bone structure was processed for a better view of the location of the region of interest.
Total lipid determination in liver. Total fat in liver samples was determined by the gravimetric method 
after lipid extraction. Lipid extraction was performed as described by Bligh and Dyer55, and the results are 
expressed as percentage.
Plasma lipoprotein profile. Equal volumes of plasma from every marmoset in each group were pooled 
and 220 μl of pooled plasma were subjected to gel filtration by fast protein liquid chromatography (FPLC) using a 
Superose 6 HR 10/30 column (Pharmacia). The samples were eluted with 150 mM NaCl, 10 mM Tris-HCl, 2 mM 
Na2-EDTA and 0.02% NaN3, pH 7.4, at a flow rate of 0.3 ml/min. Fractions of 0.4 ml were collected and cholesterol 
and triglyceride concentrations in each fraction were determined enzymatically (Centronic GmbH, Wartenberg, 
Germany).
miRNA selection. We selected the miRNAs presenting the highest sequence similarity with human miR-
NAs. Using data related to miRNAs sequence provided by The Marmoset Genome Sequencing and Analysis 
Consortium (The Common Marmoset Genome Provides Insight into Primate Biology and Evolution57), we 
compared the marmoset miRNA sequences with the assessed human miRNAs, including in our screening the 
sequences presenting 100% similarity with human miRNAs, and sequences with up to two mismatches outside 
the seed sequence (nucleotides 2–8) and/or differing in up to two nucleotides in length. The number of marmoset 
miRNAs selected was 370, to which we added miRNAs to be used as normalizing miRNAs.
RNA extraction and miRNA screening. Liver total RNA from biopsied tissue was isolated using 
Qiazol Reagent and miRNeasy Mini kit columns (Qiagen). RNA was quantified using a NanoDrop-1000 
Spectrophotometer and purity was determined by calculating the 260/280 nm and 260/230 nm ratios. RNA integ-
rity was assessed using the Agilent 2100 Bioanalyzer. For the selected (see above) miRNA screening, cDNA was 
synthetized from total RNA (1000 ng) using miScript® II RT Kit (Qiagen), following the manufacturer’s proto-
col. miRNA quantification was performed by real time PCR (qRT-PCR) using the miScript SYBR®Green qPCR 
Master Mix (Qiagen) on a 7900HT fast real time PCR system (Applied Biosystems) using a 384-well plate format. 
Reactions were performed in a final volume of 10 µl following these cycling conditions: 15 min at 95 °C for one 
cycle, then 40 cycles at 94 °C for 15 s and 58 °C for 30 s. The dissociation curve was analyzed at 95 °C for 15 s, fol-
lowed by one cycle with increasing temperature starting at 60 °C and ending at 95 °C. RNU6 and RNU1A1 were 
used as reference small RNAs for normalization. miRNA relative expression analysis was performed using the 
GenEx software (MultiD Analyses AB, Sweden).
miRNA validation. Validation of selected miRNAs from the primary screening were performed by Real-time 
RT PCR using a second different pair of primers. Reactions were performed using cDNA obtained as indicated 
previously in 384-well plates, using miScript SYBR green Mastermix (Qiagen) and gene expression determined 
using a 7900HT Fast Real-time PCR System (Applied Biosystems) as described above. Specific oligos for Callitrix 
miRNAs were used and values were normalized by the housekeeping small RNAs RNU1A1 and RNU6.
Marmoset miRNA target prediction. Marmoset transcripts 3′UTR sequences were obtained from 
Ensemble database (Dataset C_jacchus3.2.1), ending up with a set of 30642 sequences. After the selection of 
differentially expressed microRNAs, putative targets for these miRNAs were determined using the miRanda58 
algorithm v.3.3, setting a minimum alignment score of 150 as a threshold for a valid mRNA-miRNA interac-
tion. For functional analysis of these predicted targets, marmoset genes were mapped to their corresponding 
human orthologous, and enriched pathways and gene ontology (GO) biological processes were identified using 
the Genecodis enrichement analysis tool59.
Statistical analysis. Results are expressed as mean ± error standard of the mean (EPM). Kolmogorov-Smirnov 
test was used to test the normality of the data. Those data that were not parametric were log transformed. t test 
was performed to establish statistical significances between experimental groups with GraphPad Prism program, 
version 7. The level of significance was set at 5% (p < 0.05).
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